Global Dalteparin Sodium Market Outlook 2016-2021

Dalteparin is a low molecular weight heparin. It is marketed as Fragmin by Pfizer Inc. Like other low molecular weight heparins, dalteparin is used for prophylaxis or treatment of deep vein thrombosis and pulmonary embolism. It is normally administered by self-injection.

The CLOT study, published in 2003, showed that in patients with malignancy and acute venous thromboembolism, dalteparin was more effective than warfarin in reducing the risk of recurrent embolic events. Dalteparin is not superior to unfractionated heparin in preventing blood clots.

Heparins are cleared by the kidneys, but studies have shown that dalteparin does not accumulate even if kidney function is reduced.

Request Sample Report Here: http://www.reportbazzar.com/request-sample/?pid=677954&ptitle=Global+Dalteparin+Sodium+Market+Outlook+2016-2021&req=Sample

This report provides detailed analysis of worldwide markets for Dalteparin Sodium from 2011-2015 and provides extensive market forecasts 2016-2021 by region/country and subsectors. It covers the key technological and market trends in the Dalteparin Sodium market and further lays out an analysis of the factors influencing the supply/demand for Dalteparin Sodium, and the opportunities/challenges faced by industry participants. It also acts as an essential tool to companies active across the value chain and to the new entrants by enabling them to capitalize the opportunities and develop business strategies.

GCC’s report, Global Dalteparin Sodium Market Outlook 2016-2021, has been prepared based on the synthesis, analysis, and interpretation of information about the global Dalteparin Sodium market collected from specialized sources. The report covers key technological developments in the recent times and profiles leading players in the market and analyzes their key strategies. The competitive landscape section of the report provides a clear insight into the market share analysis of key industry players. The major players in the global Dalteparin Sodium market are Pfizer (USA), Reliable Biopharmaceutical (USA), Gland Pharma (India), Opocrin (Italy), Hebei Changshan (China), Changzhou Qianhong (China), Nanjing Kingfriend (China), among others.

The report provides separate comprehensive analytics for the North America, Europe, Asia-Pacific, Middle East and Africa and Rest of World. In this sector, global competitive landscape and supply/demand pattern of Dalteparin Sodium industry has been provided.

Browse Report Summary with TOC: http://www.reportbazzar.com/product/global-dalteparin-sodium-market-outlook-2016-2021/

Table of Content:
Part 1. Scope of Report
1.1 Methodology
1.2 Geographic Scope
1.3 Years Considered

Part 2. Introduction
2.1 Definition
2.2 Current Scenario
2.2 Future Scenario

Part.3 Value Chain Analysis
3.1 Upstream
3.2 Downstream

Part 4. Manufacture
4.1 Manufacturing Process
4.2 Issues and Trends
4.3 Manufacturing Costs

Part 5. Worldwide Key Vendors
5.1 Company A
5.1.1 Business Overview
5.1.2 Products Offered
5.1.3 Business Performance
5.2 Company B
5.3 Company C
5.4 Company D
5.5 Company E
5.6 Company F
5.7 Company G
5.8 Company H
5.9 Company I
5.10 Company J

Part 6. Market Overview
6.1 Global Production Volume 2011-2016
6.2 Production Volume by Region 2011-2016
6.2.1 North America
6.2.2 EMEA
6.2.3 Asia-Pacific
6.2.4 ROW
6.3 Global Production Value 2011-2016

Enquiry Before Buying: http://www.reportbazzar.com/discount-form/?pid=677954&ptitle=Global+Dalteparin+Sodium+Market+Outlook+2016-2021&req=Discount

About Us:
Reportbazzar.com is your trusted source for the most inclusive and informative assortment of market research reports designed to empower you with the latest in industry information that translates to time and cost savings for your business. We not only help you give wing to your latent business ideas but also facilitate you in taking the best informed and strategic decisions that guarantee success in your most promising business endeavors.

Contact Us:
ReportBazzar
Mary Jane
30 Wall Street, 8th floor,
New York, NY 10005.
US: +1 (212) 389-6363
India: +91 20 66528525
Email Id: sales@reportbazzar.com
Website: http://www.reportbazzar.com/

This release was published on openPR.